Royal Bank of Canada’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Royal Bank of Canada’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,000	Closed	–	–	6990
2016 Q3	$0	Hold	1,000	–	–	﹤0.01%	6766
2016 Q2	$0	Hold	1,000	–	–	﹤0.01%	6719
2016 Q1	$0	Hold	1,000	–	–	﹤0.01%	6938
2015 Q4	$0	Hold	1,000	–	–	﹤0.01%	7066
2015 Q3	$1K	Buy	+1,000	New	+$512	﹤0.01%	6566
2014 Q4	–	Sell	-5,000	Closed	-$5K	–	6444
2014 Q3	$5K	Buy	+5,000	New	+$4.85K	﹤0.01%	5662

Other funds holding PVCT

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

Royal Bank of Canada's PVCT Position: Q4 2016 in Review

Royal Bank of Canada sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 1,000 shares.

Royal Bank of Canada first reported a position in PVCT in Q3 2014 and held it in 6 quarters. The position peaked at $5K in Q3 2014. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

Royal Bank of Canada reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
Royal Bank of Canada sold 1,000 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016.
Royal Bank of Canada first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q3 2014 and held it in 6 quarters.
Royal Bank of Canada's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $5K in Q3 2014.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Royal Bank of Canada's 13F filing for Q4 2016, filed 14 Feb 2017.